⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark KevinM.D.

Internal Medicine · Munster, IN 46321

NPI: 1134161169

Share:

13

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriberHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

9,708

Total Claims

$1.1M

Drug Cost

512

Beneficiaries

$2,245

Cost/Patient

Risk Score Breakdown 13/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-22%

Opioid rate vs peers

1.8% vs 2.2% avg

+59%

Cost per patient vs peers

$2,245 vs $1,411 avg

+12%

Brand preference vs peers

11.9% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.8%

Opioid Rate

170

Opioid Claims

$1,895

Opioid Cost

Long-Acting Rate

Brand vs Generic

88% generic

Brand: 1,149 claims · $968K

Generic: 8,499 claims · $178K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Dulaglutide79$124K
Apixaban73$101K
Etanercept12$82K
Sitagliptin Phosphate72$75K
Rivaroxaban61$74K
Tirzepatide38$55K
Fluticasone/Vilanterol92$50K
Semaglutide27$43K
Dapagliflozin Propanediol35$41K
Linagliptin38$34K
Tiotropium Bromide23$23K
Canagliflozin23$21K
Semaglutide13$16K
Evolocumab14$13K
Fluticasone Propion/Salmeterol14$13K

Prescribing Profile

137

Unique Drugs

$373K

IRA Negotiated Drugs

$239K

GLP-1 Drugs

13.0

Anomaly Score

Patient Profile

75

Avg Age

45%

Female

1.33

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data